Commerzbank Aktiengesellschaft FI Reduces Stock Position in Cigna Group $CI

Commerzbank Aktiengesellschaft FI trimmed its holdings in Cigna Group (NYSE:CI) by 17.6% during the first quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 15,145 shares of the health services provider’s stock after selling 3,243 shares during the period. Commerzbank Aktiengesellschaft FI’s holdings in Cigna Group were worth $4,040,000 as of its most recent SEC filing.

Other institutional investors and hedge funds also recently made changes to their positions in the company. Wilkerson Advisory Group LLC bought a new stake in shares of Cigna Group in the fourth quarter worth $25,000. Beacon Financial Strategies CORP bought a new position in Cigna Group during the 4th quarter valued at $28,000. Kemnay Advisory Services Inc. acquired a new position in Cigna Group during the 4th quarter worth $29,000. Prosperity Bancshares Inc acquired a new position in Cigna Group during the 4th quarter worth $29,000. Finally, Cedar Mountain Advisors LLC increased its position in shares of Cigna Group by 161.9% in the 1st quarter. Cedar Mountain Advisors LLC now owns 110 shares of the health services provider’s stock worth $29,000 after purchasing an additional 68 shares during the last quarter. 86.99% of the stock is currently owned by hedge funds and other institutional investors.

Cigna Group Stock Performance

Shares of CI stock opened at $284.01 on Tuesday. The company has a quick ratio of 0.73, a current ratio of 0.73 and a debt-to-equity ratio of 0.69. The business has a 50 day moving average of $286.59 and a two-hundred day moving average of $280.48. The company has a market cap of $75.13 billion, a P/E ratio of 12.04, a PEG ratio of 1.08 and a beta of 0.29. Cigna Group has a 52 week low of $239.51 and a 52 week high of $315.47.

Cigna Group (NYSE:CI) last released its quarterly earnings data on Thursday, April 30th. The health services provider reported $7.79 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $7.60 by $0.19. The business had revenue of $68.52 billion during the quarter, compared to analyst estimates of $66.29 billion. Cigna Group had a return on equity of 19.75% and a net margin of 2.26%.The business’s revenue for the quarter was up 4.6% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $6.74 EPS. Cigna Group has set its FY 2026 guidance at 30.350- EPS. As a group, analysts anticipate that Cigna Group will post 30.39 EPS for the current year.

Cigna Group Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Thursday, June 18th. Stockholders of record on Thursday, June 4th were issued a dividend of $1.56 per share. The ex-dividend date of this dividend was Thursday, June 4th. This represents a $6.24 annualized dividend and a dividend yield of 2.2%. Cigna Group’s payout ratio is 26.45%.

Analyst Upgrades and Downgrades

Several equities analysts have recently commented on CI shares. Raymond James Financial set a $340.00 price target on shares of Cigna Group in a research report on Friday, May 1st. Guggenheim boosted their price objective on Cigna Group from $334.00 to $338.00 and gave the company a “buy” rating in a report on Monday, May 4th. The Goldman Sachs Group upped their price objective on Cigna Group from $335.00 to $340.00 and gave the company a “buy” rating in a research note on Monday, May 4th. Weiss Ratings reaffirmed a “hold (c)” rating on shares of Cigna Group in a report on Monday, June 1st. Finally, Wells Fargo & Company lifted their target price on Cigna Group from $300.00 to $305.00 and gave the stock an “equal weight” rating in a research report on Friday, May 1st. One investment analyst has rated the stock with a Strong Buy rating, fifteen have assigned a Buy rating and six have given a Hold rating to the company. According to MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $338.80.

Insider Buying and Selling at Cigna Group

In other news, CEO David Cordani sold 201,878 shares of the company’s stock in a transaction dated Tuesday, May 12th. The shares were sold at an average price of $292.82, for a total transaction of $59,113,915.96. Following the completion of the transaction, the chief executive officer owned 34,337 shares in the company, valued at approximately $10,054,560.34. This represents a 85.46% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CAO Jamie G. Kates sold 899 shares of the stock in a transaction dated Friday, June 12th. The stock was sold at an average price of $298.61, for a total transaction of $268,450.39. Following the completion of the sale, the chief accounting officer directly owned 2,368 shares in the company, valued at approximately $707,108.48. This trade represents a 27.52% decrease in their position. The SEC filing for this sale provides additional information. Insiders own 0.60% of the company’s stock.

Cigna Group Company Profile

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.